Emgality (galcanezumab-gnlm) is one of four injectable CGRP monoclonal antibodies approved to prevent migraine, and it is the only one also approved for episodic cluster headache. It is a self-administered shot, usually one prefilled pen a month, and it has no generic. Biologics like this one cannot be copied the way a small-molecule pill can, so there is no $12 version waiting at Walmart.
What makes Emgality unusual among the CGRP preventives is that Eli Lilly publishes both a list price and a self-pay price, and the gap between them is enormous. This guide prices every route a cash payer can actually take, using figures verified on September 2, 2026 against Lilly’s own pricing page, a Texas state drug-price disclosure filing, two federal CMS datasets and a live pharmacy discount page. It covers money and logistics only. Whether Emgality is right for you is a conversation with your prescriber.
What Does Emgality Cost Without Insurance?
Every figure below is normalized to one month of migraine prevention, which is one 120 mg prefilled pen or syringe. Prices were verified September 2, 2026.
| Route | Low | Typical | High |
|---|---|---|---|
| Lilly list price (WAC), 120 mg pen or syringe | $763.94 | $763.94 | $763.94 |
| Average retail cash price (SingleCare) | $1,020.75 | $1,020.75 | $1,020.75 |
| Named-chain retail cash price | $901.99 | $916.83 | $1,012.69 |
| SingleCare discount-card price | $626.45 | $626.45 | $794.15 |
| LillyDirect self-pay (home delivery) | $299.00 | $299.00 | $299.00 |
| Pharmacy acquisition cost (CMS NADAC) | $734.22 | $734.22 | $734.53 |
| Emgality Savings Card (commercial insurance only) | $0 | $35.00 | $35.00 |
| Lilly Cares Foundation (income-qualified) | $0 | $0 | $0 |
| Episodic cluster headache, 300 mg (three 100 mg syringes) | $1,837.77 | $1,854.22 | $1,909.85 |
Two independent sources agree on the list price. Lilly’s own pricing page states $763.94 for one 120 mg prefilled pen or syringe, citing a wholesale acquisition cost accessed January 1, 2026. The Texas Department of State Health Services 2026 Annual WAC Report, which collects manufacturer-reported January 1, 2026 list prices, shows Eli Lilly reporting $763.94 for both the pen (NDC 0002-1436-11) and the syringe (NDC 0002-2377-11), plus $1,909.85 for the three-syringe 100 mg cluster-headache pack.
CMS’s National Average Drug Acquisition Cost file, effective August 19, 2026, puts what pharmacies actually pay at $734.22 per 120 mg pen and $734.53 per syringe, about 96% of list. That is the floor under any retail price, and it explains why nobody sells Emgality for $200 at the counter.
The retail rows come from SingleCare’s live Emgality page, updated September 2, 2026, which puts the average retail price at $1,020.75 per pen, shows named-chain retail prices from $901.99 to $1,012.69, and shows card prices from $626.45 to $794.15 depending on the chain. Treat the named-chain figures as illustrative of the spread rather than as fixed prices, because a single chain’s card price moves between visits. The stable numbers on that page are the average retail price and the headline card price.
What Drives the Price
There is no generic and there will not be one soon. Emgality is a biologic, so a competitor would have to file a biosimilar application, run comparative studies and clear FDA licensure. No galcanezumab biosimilar exists. The NADAC file confirms it, showing no corresponding generic acquisition cost for any Emgality NDC.
Loading dose in month one. Migraine prevention starts at 240 mg, which is two pens at once, then drops to 120 mg monthly. Lilly states this in its pricing footnotes. Budget for roughly double in the first month on any cash route.
Which condition you are treating. Episodic cluster headache uses 300 mg, dispensed as three 100 mg syringes at the start of a cluster period. That pack lists at $1,909.85 and has a NADAC of $612.59 per mL, or about $1,837.77 for the three-syringe kit, so cluster dosing costs roughly two and a half times a migraine month.
Where you buy it. The single biggest variable for an uninsured patient is not geography, it is channel. LillyDirect self-pay at $299 a month is less than a third of the average retail counter price of $1,020.75, and less than half a discount-card price.
Specialty pharmacy routing. CGRP injectables are often filled through specialty pharmacies rather than the corner drugstore, which is part of why quoted prices vary so widely by pharmacy. It is worth calling more than one.
Cash Price vs. Insurance
For most drugs on this site, insurance beats cash. Emgality is a case where it depends entirely on which insurance.
CMS’s Medicare Part D Spending by Drug dashboard, published June 2026 with 2024 data, shows what the program actually paid: $844.93 per claim for the Emgality pen and $1,066.28 per claim for the syringe, across 51,883 pen beneficiaries and 9,561 syringe beneficiaries. That is total spending, not what a patient paid, and it sits well above LillyDirect’s $299 self-pay price. A cash payer buying direct is currently getting a better price per month than Medicare Part D pays.
If you have commercial insurance that covers Emgality, the savings card takes you to as little as $35 for a one-month fill, and there is no cash route that beats that. But the card’s own terms exclude anyone on Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA or TRICARE, cap assistance at $4,900 a calendar year, and expire December 31, 2026. If you are uninsured, the card is not an option at all, which is the single most common misunderstanding about CGRP pricing.
One more wrinkle worth knowing: paying cash means the spend does not count toward a deductible or out-of-pocket maximum. If you have a high-deductible plan and expect a big medical year, running the claim through insurance may still be the better long-run move even when the cash price looks better this month.
How to Pay Less
Start with LillyDirect self-pay. Lilly’s home-delivery pharmacy lists Emgality at a self-pay price starting at $299 a month for the 120 mg prefilled pen. Your prescriber sends the prescription to the LillyDirect pharmacy, and a pharmacy partner contacts you. Confirm the current price before you commit, since manufacturer self-pay ladders change.
Apply to Lilly Cares if your income qualifies. The Lilly Cares Foundation lists Emgality as a Group 1 medication: free to patients with no insurance or Medicare Part D whose household adjusted gross income is at or below 300% of the 2026 federal poverty guidelines. The published limits are $47,880 for one person, $64,920 for two, $81,960 for three, $99,000 for four, $116,040 for five and $133,080 for six. Alaska and Hawaii residents have to call for their limits.
Price the discount cards before you fill. SingleCare’s Emgality page showed a card price of $626.45 per pen on September 2, 2026, against an average retail price of $1,020.75. That is a real saving if the direct route is not available to you, but it is still double the LillyDirect price. Our GoodRx vs. SingleCare comparison walks through how to check both quickly, and card prices move, so re-check at each refill.
Compare the whole class before you settle. All four self-injected CGRP preventives sit within about $30 of each other at list, but their cash routes differ enormously. See Ajovy and Aimovig, which is currently sold to cash payers at $299 a month through a discount partnership, and Vyepti, which is infused in a clinic rather than self-injected and is priced as a medical claim.
Ask about the acute side of the bill. Preventives are only half of most migraine budgets. If you are also buying rescue medication, sumatriptan generics run a small fraction of the branded gepants like Nurtec, Ubrelvy and Qulipta.
Get the visit priced too. A specialist visit to get the prescription written is its own bill. Check what a cash consult should cost with our fair price checker, and if the clinic is hospital-owned, ask about charity care before the appointment rather than after the statement arrives. If a bill has already gone out, our guide to negotiating medical bills covers what to say and to whom.
The Bottom Line
At list, Emgality costs $763.94 a month, or about $9,931 for a first year that includes the double loading dose. At the pharmacy counter without help, expect closer to $1,021. But the honest headline for an uninsured reader is $299, because that is what Lilly’s own pharmacy charges self-pay patients as of September 2026, and $0 if your household income is under 300% of the federal poverty level.
The trap to avoid is the $35 savings card. It is advertised heavily, it is real, and it is useless without commercial insurance. If you are paying cash, skip it and go straight to the direct-purchase price or the foundation application.